Adult autoimmune thrombocytopenia: Diagnosis and treatment;Autoimmunthrombozytopenie (AITP) des erwachsenen: Klinik, diagnose und therapie

Wiener Klinische Wochenschrift

Volumn 118, Issue 9-10, 2006, Pages 255-264

  Lechner, Klaus ^a   Weltermann, Ansgar ^a   Pabinger, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

AITP; Diagnosis; Rituximab; Splenectomy; Therapy

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; PREDNISOLONE; RITUXIMAB; STEROID; THROMBOCYTE ANTIBODY; THROMBOPOIETIN;

AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; BONE MARROW EXAMINATION; DIFFERENTIAL DIAGNOSIS; HUMAN; INCIDENCE; INFECTION RISK; LAPAROSCOPIC SURGERY; MORBIDITY; MORTALITY; PALPATION; PREOPERATIVE CARE; PROGNOSIS; REVIEW; RISK FACTOR; SEPTICEMIA; SPLEEN; SPLENECTOMY; STREPTOCOCCUS INFECTION; THROMBOCYTE COUNT; VACCINATION;

ADULT; ANTI-INFLAMMATORY AGENTS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK ASSESSMENT; SPLENECTOMY; TREATMENT OUTCOME;

EID: 33745765878     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0602-5     Document Type: Review

References (87)

1. Sailer T, Weltermann A, Zoghlami C, Kyrle PA, Lechner K, Pabinger I (2003) Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia. Hematol J 4 (5): 366-369
2. Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94 (3): 909-913
3. Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR; On behalf of the Northern Region Haematology Group (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122 (6): 966-974
4. Linares M, Cervero A, Colomina P, Pastor E, Lopez A, Perez A, Perella M, Carbonell F (1995) Chronic idiopathic thrombocytopenic purpura in the elderly. Acta Haematol 93 (2-4): 80-82
5. Guthrie TH Jr, Brannan DP, Prisant LM (1988) Idiopathic thrombocytopenic purpura in the older adult patient. Am J Med Sci 296 (1): 17-21
6. Taillan B, Hastier P, Ferrari E, Fuzibet JG, Gratecos N, Vinti H, Pesce A, Dujardin P (1991) Idiopathic thrombocytopenic purpura in elderly subjects Presse Med 20 (34): 1651-1654
7. Cines DB, Bussel JB, McMillan RB, Zehnder JL (2004) Congenital and acquired thrombocytopenia. Hematology (Am Soc Hematol Educ Program), pp 390-406
8. Schrezenmeier H, Muller H, Gunsilius E, Heimpel H, Seifried E (1995) Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis. Thromb Haemost 73 (3): 506-513
9. van der Meer W, Allebes W, Simon A, van Berkel Y, de Keijzer MH (2002) Pseudothrombocytopenia: a report of a new method to count platelets in a patient with EDTA - and temperature-independent antibodies of the IgM type. Eur J Haematol 69 (4): 243-247
10. Shiozaki H, Miyawaki S, Kuwaki T, Hagiwara T, Kato T, Miyazaki H (2000) Autoantibodies neutralizing thrombopoietin in a patient with amegakaryocytic thrombocytopenic purpura. Blood 95 (6): 2187-2188
11. Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98 (12): 3241-3248
12. Felderbauer P, Ritter PR, Mattern D, Schmitz F, Bulut K, Ansorge N, Schmitt-Graeff A, Schmidt WE, Baier JE (2004) Acquired pure megakaryocytic aplasia: a separate haematological disease a syndrome with multiple causes? Eur J Haematol 72 (6): 451-454
13. Fureder W, Mitterbauer G, Thalhammer R, Geissler K, Panzer S, Krebs M, Simonitsch-Klupp I, Sperr WR, Lechner K, Kyrie PA (2002) Clonal T cell-mediated cyclic thrombocytopenia. Br J Haematol 119 (4): 1059-1061
14. Sashida G, Takaku TI, Shoji N, Nishimaki J, Ito Y, Miyazawa K, Kimura Y, hyashiki JH, Ohyashiki K (2003) Clinicohematologic features of myelodysplastic syndrome presenting as isolated hrombocytopenia: an entity with a relatively favorable prognosis. Leuk Lymphoma 44 (4): 653-658
15. Mainwaring CJ, Shutt J, James CM (2002) Not all cases of idiopathic thrombocytopenic purpura are at they might first seem. Clin Lab Haematol 24 (4): 261-262
16. Jubelirer SJ, Harpold R (2002) The role of the bone marrow examination in the diagnosis of immune thrombocytopenic purpura: case series and literature review. Clin Appl Thromb Hemost 8 (1): 73-76
17. McMillan R, Nugent D (2005) The effect of antiplatelet autoantibodies on megakaryocytopoiesis. Int J Hematol 81 (2): 94-99
18. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 (1): 3-40
19. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70 (6): 1722-1726
20. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH (1996) Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 88 (1): 194-201
21. McMillan R (2005) The role of antiplatelet autoantibody assays in the diagnosis of immune thrombocytopenic purpura. Curr Hematol Rep 4 (2): 160-165
22. Davoren A, Bussel J, Curtis BR, Moghaddam M, Aster RH, McFarland JG (2005) Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP). Am J Hematol 78 (3): 193-197
23. Hagenstrom H, Schlenke P, Hennig H, Kirchner H, Kluter H (2000) Quantification of platelet-associated IgG for differential diagnosis of patients with thrombocytopenia. Thromb Haemost 84 (5): 779-783
24. Kosugi S, Kurata Y, Tomiyama Y, Tahara T, Kato T, Tadokoro S, Shiraga M, Honda S, Kanakura Y, Matsuzawa Y (1996) Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol 93 (3): 704-706
25. Porcelijn L, Folman CC, Bossers B, Huiskes E, Overbeeke MA, v d Schoot CE, de Haas M, von dem Borne AE (1998) The diagnostic value of thrombopoietin level measurements in thrombocytopenia. Thromb Haemost 79 (6): 1101-1105
26. Emmons RV, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood. 15;87 (10): 4068-4071
27. Sakane Y, Wada H, Kazuyo H, Shimura M, Nakasaki T, Katayama N, Nishikawa M, Deguchi K, Mori Y, Mori Y, Shiku H, Tahara T, Kato T (1998) Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. Blood Coagul Fibrinolysis 9 (4): 315-321
28. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, Matsumoto K, Hirata R, Domitsu K, Kobayashi M (2005) Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol 128 (5): 698-702
29. Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P (1992) Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol 48 (3): 168-172
30. Peltier JY, Lambin P, Doinel C, Courouce AM, Rouger P, Lefrere JJ (1991) Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a 5-year prospective study. AIDS 5 (4): 381-384
31. Rajan SK, Espina BM, Liebman HA (2005) Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol 129 (6): 818-824
32. Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, Oksenhendler E, Schaeffer A, Bierling P, Godeau B (2004) Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 83 (4): 254-263
33. Vantelon JM, Godeau B, Andre C, Bierling P (2000) Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset. Thromb Haemost 83 (1): 42-45
34. Kurata Y, Miyagawa S, Kosugi S, Kashiwagi H, Honda S, Mizutani H, Tomiyama Y, Kanayama Y, Matsuzawa Y (1994) High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura. Thromb Haemost 71 (2): 184-187
35. Diz-Kucukkaya R, Hacihanefioglu A, Yenerel M, Turgut M, Keskin H, Nalcaci M, Inanc M (2001) Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 98 (6): 1760-1764
36. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH (2001) American Society of Clinical Oncology. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (5): 1519-1538
37. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97 (9): 2549-2554
38. Barnes C, Blanchette V, Canning P, Carcao M (2005) Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med 15 (2): 145-150
39. Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F, Cheze S, Legouffe E, Hulin C, Grange MJ, Fain O, Bierling P French ATIP Study Group (2002) Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 359 (9300): 23-29
40. Bellucci S, Charpak Y, Chastang C, Tobelem G (1988) Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 71 (4): 1165-1169
41. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F, Sciarra A, Pernotti AP, Adomo G, Amadori S, et al (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98 (5): 436-442
42. Lechner K, Rintelen C, Weltermann A, Kyrle PA, Pabinger I (2002) The risk of bleeding and the risk of overtreatment in immune thrombocytopenic purpura. Haematologica; 87: 145
43. Lechner K (2001) Management of adult immune thrombocytopenia. Rev Clin Exp Hematol 5: 222-235
44. Bierling P, Godeau B (2004) Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on. Vox Sang 86 (1): 8-14
45. Schiavotto C, Ruggeri M, Rodeghiero F (1993) Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 78 [6 Suppl 2]: 35-40
46. Hefer D, Jaloudi M (2004) Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature. Ann Hematol 83 (10): 661-665
47. Sati HI, Ahya R, Watson HG (2001) Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. Br J Haematol 113 (2): 556-557
48. Feuillet L, Guedj E, Laksiri N, Philip E, Habib G, Pelletier J, Ali Cherif A (2004) Deep vein thrombosis after intravenous immunoglobulins associated with methylprednisolone. Thromb Haemost 92 (3): 662-665
49. Cooper N, Woloski BM, Fodero EM, Novoa M, Leber M, Beer JH, Bussel JB (2002) Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood 99 (6): 1922-1927
50. Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, Barbui T, Tura S, Baccaranion M; Gruppo Italiano per lo Studio delle Malattie Ematologiche dell'Adulto (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 90 (1): 72-77
51. Zoghlami-Rintelen C, Weltermann A, Bittermann C, Kyrle PA, Pabinger I, Lechner K, Wenzl E (2003) Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia. Ann Hematol 82 (5): 290-294
52. Kumar S, Diehn FE, Gertz MA, Tefferi A (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81 (6): 312-319
53. Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104 (9): 2623-2634
54. Delaitre B, Champault G, Barrat C, Gossot D, Bresler L, Meyer C, Collet D, Samama G (2000) Laparoscopic splenectomy for hematologic diseases. Study of 275 cases. Ann Chir 125 (6): 522-529
55. Pietrabissa A, Moretto C, Antonelli G, Morelli L, Marciano E, Mosca F (2004) Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc 18 (7): 1140-1143
56. Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241 (2): 208-216
57. Schilling RF (1995) Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med 122 (3): 187-188
58. Keidar A, Feldman M, Szold A (2005) Analysis of outcome of laparoscopic splenectomy for idiopathic thrombocytopenic purpura by platelet count. Am J Hematol 80 (2): 95-100
59. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN (2004) Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med 140 (2): 112-120
60. McMillan R (1997) Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 126 (4): 307-314
61. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B (2000) The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 160 (11): 1630-1638
62. Bourgeois E, Caulier MT, Delarozee C, Brouillard M, Bauters F, Fenaux P (2003) Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis. Br J Haematol 120 (6): 1079-1088
63. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced Osteoporosis Intervention Study Group. N Engl J Med 339 (5): 292-299
64. Stasi R, Pagano A, Stipa E, Amadori S (2001) Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 98 (4): 952-957
65. Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 125 (2): 232-239
66. Stasi R, Stipa E, Forte V, Meo P, Amadori S (2002) Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood 99 (10): 3872-3873
67. Godeau B, Durand JM, Roudot-Thoraval F, Tenneze A, Oksenhendler E, Kaplanski G, Schaeffer A, Bierling P (1997) Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases. Br J Haematol 97 (2): 336-339
68. Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A (2005) Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults - a report on 90 patients. Eur J Haematol 75 (4): 328-331
69. Emilia G, Morselli M, Luppi M, Longo G, Marasca R, Gandini G, Ferrara L, D'Apollo N, Potenza L, Bertesi M, Torelli G (2002) Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. Blood 99 (4): 1482-1485
70. Kotb R, Pinganaud C, Trichet C, Lambotte O, Dreyfus M, Delfraissy JF, Tchernia G, Goujard C (2005) Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study. Eur J Haematol 75 (1): 60-64
71. Howard J, Hoffbrand AV, Prentice HG, Mehta A (2002) Mycophenolate mofetil for the treatment of refractory autoimmune haemolytic anaemia and auto-immune thrombocytopenia purpura. Br J Haematol 117 (3): 712-715
72. Zhang WG, Ji L, Cao XM, Chen YX, He AL, Liu J, Zhao WH, Zou SP (2005) Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura. Acta Pharmacol Sin 26 (5): 598-602
73. Huhn RD, Fogarty PF, Nakamura R, Read EJ, Leitman SF, Rick ME, Kimball J, Greene A, Hansmann K, Gratwohl A, Young N, Barrett AJ, Dunbar CE (2003) High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 101 (1): 71-77
74. Passweg JR (2004) Haematopoietic stem cell transplantation for immune thrombopenia and other refractory autoimmune cytopenias. Best Pract Res Clin Haematol 17 (2): 305-315
75. Nomura S, Dan K, Hotta T, Fujimura K, Ikeda Y (2002) Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 100 (2): 728-730
76. Erickson-Miller CL, DeLorme E, Tian SS, Hopson CB, Stark K, Giampa L, Valoret EI, Duffy KJ, Luengo JL, Rosen J, Miller SG, Dillon SB, Lamb P (2005) Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist. Exp Hematol 33 (1): 85-93
77. Selby LA, Hess D, Shashidar H, de Villiers WJ, Selby LA (2004) Crohn's disease, infliximab and idiopathic thrombocytopenic purpura. Inflamm Bowel Dis 10 (5): 698-700
78. McMinn JR Jr, Cohen S, Moore J, Lilly S, Parkhurst J, Tarantino MD, Terrell DR, George JN (2003) Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol 73 (2): 135-140
79. Lim SH, Hale G, Marcus RE, Waldmann H, Baglin TP (1993) CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura. Br J Haematol 84 (3): 542-544
80. Willis F, Marsh JC, Bevan DH, Killick SB, Lucas G, Griffiths R, Ouwehand W, Hale G, Waldmann H, Gordon-Smith EC (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 114 (4): 891-898
81. Kuwana M, Nomura S, Fujimura K, Nagasawa T, Muto Y, Kurata Y, Tanaka S, Ikeda Y (2004) Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura. Blood 103 (4): 1229-1236
82. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G (1998) Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 352 (9131): 878
83. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D (2005) Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 118 (4): 414-419
84. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T (2005) Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 100 (6): 1265-1270
85. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M (2004) Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 164 (17): 1904-1907
86. Michel M, Cooper N, Jean C, Frissora C, Bussel JB (2004) Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 103 (3): 890-896
87. Vianelli N, Valdre L, Fiacchini M, de Vivo A, Gugliotta L, Catani L, Lemoli RM, Poli M, Tura S (2001) Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 86 (5): 504-509